The case for tumour-agnostic reimbursement of dual immunotherapy.
Saved in:
| Title: | The case for tumour-agnostic reimbursement of dual immunotherapy. |
|---|---|
| Authors: | Subbiah V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: viveksubbiah@outlook.com., Kurzrock R; Center for Precision Oncology and Rare Cancers at Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA; WIN Consortium, Paris, France. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 18; Vol. 241, pp. 116784. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0852 |
|---|---|
| DOI: | 10.1016/j.ejca.2026.116784 |
